Dr. Thomas E. Stinchcombe
Overview
I am a part of the thoracic oncology program. I work with patients who have cancers of the lung, which includes non-small cell lung cancer, small cell lung cancer, and mesothelioma. My focus is on clinical care, clinical trials, and developing new therapies for these diseases. When I first meet with a patient, I want them to understand what their diagnosis is, because there are actually multiple diagnoses of lung cancer and each are treated differently. Then I discuss with a patient whether they are a candidate for therapies such as molecular therapy or immunotherapy, and make sure they have a clear understanding of the treatment plan. There are some very promising new therapies for these diseases and we are fortunate to have those available to patients here at Duke. That’s one of the unique things we offer as an academic medical center.
Dr. Stinchcombe is rated as an Experienced provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
His clinical research consists of co-authoring 173 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Endometrial Stromal Sarcoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Stinchcombe has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Rex Hospital Inc
John Boggess is a Gynecologic Oncologist and an Oncologist in Raleigh, North Carolina. Dr. Boggess is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Cervical Cancer, Salpingo-Oophorectomy, and Oophorectomy. Dr. Boggess is currently accepting new patients.
University Of North Carolina At Chapel Hill
Linda Van Le is a Gynecologic Oncologist and an Oncologist in Chapel Hill, North Carolina. Dr. Van Le is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. Her top areas of expertise are Ovarian Cancer, Vulvar Cancer, Endometrial Cancer, Vulvectomy, and Hysterectomy. Dr. Van Le is currently accepting new patients.
University Of North Carolina At Chapel Hill
Victoria Bae-Jump is a Gynecologic Oncologist and an Oncologist in Chapel Hill, North Carolina. Dr. Bae-Jump is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Vulvar Cancer, Salpingo-Oophorectomy, and Hysterectomy. Dr. Bae-Jump is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Stinchcombe isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Stinchcombe isElite. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Stinchcombe isElite. Learn about Small Cell Lung Cancer (SCLC).
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Stinchcombe isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Stinchcombe isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Stinchcombe isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Stinchcombe isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Stinchcombe isDistinguished. Learn about Pleuropulmonary Blastoma.
- Squamous Cell Lung CarcinomaDr. Stinchcombe isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- MesotheliomaDr. Stinchcombe isAdvanced. Learn about Mesothelioma.
- Metastatic Pleural TumorDr. Stinchcombe isAdvanced. Learn about Metastatic Pleural Tumor.
- Posterior Fossa TumorDr. Stinchcombe isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Stinchcombe isAdvanced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Experienced
- Adult Soft Tissue SarcomaDr. Stinchcombe isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Stinchcombe isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Stinchcombe isExperienced. Learn about Anal Cancer.
- Bone TumorDr. Stinchcombe isExperienced. Learn about Bone Tumor.
- Colorectal CancerDr. Stinchcombe isExperienced. Learn about Colorectal Cancer.
- Endometrial Stromal SarcomaDr. Stinchcombe isExperienced. Learn about Endometrial Stromal Sarcoma.